PDF(Pubmed)
Abstract：
Healthcare ultimately aims to eradicate diseases and restore normality to people\'s lives. However, until this is achieved for every person, there is a need to support and assist patients with psoriasis using non-pharmacological interventions. These \'adjuvant\' approaches have received little attention, whereas dermatologists and researchers strive for better pharmacological therapy. Here, we aimed to perform a scoping review to identify and catalogue non-pharmacological interventions for patients with psoriasis.
A scoping review.
All healthcare settings.
EMBASE, PubMed, CINAHL, PsycINFO and Scopus databases were searched from their inception to June 2022. Irrespective of the study type, the studies included non-pharmacological interventions for patients with psoriasis. This theme was extracted from the included articles. Two reviewers independently screened and analysed the data.
From 1322 initial records, 71 studies were identified and analysed. Non-pharmacological interventions for patients with psoriasis include two levels: organisational and individual. The organisational non-pharmacological interventions included the nationwide healthcare model (PsPSP, ProvenCare, German PsoHealth and Psoriasis Network, IMPROVE model and PsoWell clinic), innovative teledermatology models (mHealth app, electronic Targeted Intervention for Psoriasis study and therapist-guided internet-based cognitive and behavioural treatments) and multidisciplinary interventions. The individual non-pharmacological interventions included educational interventions (therapeutic patient education, psychoeducational intervention and self-management education), psychosocial interventions (cognitive and behavioural treatments, self-help and peer-to-peer support programmes) and others (happify and motivational interviewing-based training).
Based on previous literature, a nationwide healthcare model protocol was constructed for patients with psoriasis. This provided the direction for developing a new psoriasis healthcare model and a basis for summarising the non-pharmacological interventions for patients with psoriasis, which helps them adjust to changes in the skin disease.
A scoping review.
All healthcare settings.
EMBASE, PubMed, CINAHL, PsycINFO and Scopus databases were searched from their inception to June 2022. Irrespective of the study type, the studies included non-pharmacological interventions for patients with psoriasis. This theme was extracted from the included articles. Two reviewers independently screened and analysed the data.
From 1322 initial records, 71 studies were identified and analysed. Non-pharmacological interventions for patients with psoriasis include two levels: organisational and individual. The organisational non-pharmacological interventions included the nationwide healthcare model (PsPSP, ProvenCare, German PsoHealth and Psoriasis Network, IMPROVE model and PsoWell clinic), innovative teledermatology models (mHealth app, electronic Targeted Intervention for Psoriasis study and therapist-guided internet-based cognitive and behavioural treatments) and multidisciplinary interventions. The individual non-pharmacological interventions included educational interventions (therapeutic patient education, psychoeducational intervention and self-management education), psychosocial interventions (cognitive and behavioural treatments, self-help and peer-to-peer support programmes) and others (happify and motivational interviewing-based training).
Based on previous literature, a nationwide healthcare model protocol was constructed for patients with psoriasis. This provided the direction for developing a new psoriasis healthcare model and a basis for summarising the non-pharmacological interventions for patients with psoriasis, which helps them adjust to changes in the skin disease.
摘要：
目标：医疗保健的最终目标是根除疾病，恢复正常生活。然而,直到每个人都能做到这一点，有必要使用非药物干预来支持和协助银屑病患者.这些“佐剂”方法很少受到关注，而皮肤科医生和研究人员则努力寻求更好的药物治疗。这里,我们的目的是进行范围审查,以确定和分类银屑病患者的非药物干预措施.
方法：范围审查。
方法：所有医疗环境。
方法：EMBASE，PubMed,CINAHL,PsycINFO和Scopus数据库从成立到2022年6月进行了搜索。无论研究类型如何，研究包括对银屑病患者的非药物干预.这个主题是从包含的文章中提取出来的。两名审阅者独立筛选并分析了数据。
结果：来自1322个初始记录，对71项研究进行了鉴定和分析。银屑病患者的非药物干预包括两个层面：组织和个体。组织非药物干预措施包括全国性的医疗保健模式(PsPSP，ProvenCare,德国PsoHealth和牛皮癣网络，改进模型和PsoWell诊所)，创新的远程皮肤病学模型(mHealthapp，银屑病研究的电子针对性干预和治疗师指导的基于互联网的认知和行为治疗）和多学科干预。个人非药物干预包括教育干预(治疗性患者教育，心理教育干预和自我管理教育)，心理社会干预(认知和行为治疗，自助和对等支持计划）和其他（基于快乐和激励面试的培训）。
结论：根据以前的文献，我们为银屑病患者构建了一项全国性的医疗保健模式方案.这为开发新的银屑病医疗模式提供了方向，也为总结银屑病患者的非药物干预提供了基础。这有助于他们适应皮肤病的变化。
方法：范围审查。
方法：所有医疗环境。
方法：EMBASE，PubMed,CINAHL,PsycINFO和Scopus数据库从成立到2022年6月进行了搜索。无论研究类型如何，研究包括对银屑病患者的非药物干预.这个主题是从包含的文章中提取出来的。两名审阅者独立筛选并分析了数据。
结果：来自1322个初始记录，对71项研究进行了鉴定和分析。银屑病患者的非药物干预包括两个层面：组织和个体。组织非药物干预措施包括全国性的医疗保健模式(PsPSP，ProvenCare,德国PsoHealth和牛皮癣网络，改进模型和PsoWell诊所)，创新的远程皮肤病学模型(mHealthapp，银屑病研究的电子针对性干预和治疗师指导的基于互联网的认知和行为治疗）和多学科干预。个人非药物干预包括教育干预(治疗性患者教育，心理教育干预和自我管理教育)，心理社会干预(认知和行为治疗，自助和对等支持计划）和其他（基于快乐和激励面试的培训）。
结论：根据以前的文献，我们为银屑病患者构建了一项全国性的医疗保健模式方案.这为开发新的银屑病医疗模式提供了方向，也为总结银屑病患者的非药物干预提供了基础。这有助于他们适应皮肤病的变化。
